Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…ived high-dose proton pump inhibitor twice daily and 14 days of sucralfate (2 g, three times daily). Adjunct argon plasma coagulation (APC…
…The most common symptoms were reflux (32%) and dysphagia (28%). Proton pump inhibitor use was high (81%). Both anticentromere (p=<0.001) and anti-Scl…
…is, 50% of (n=46) patients were taking a proton pump inhibitor (PPI), 59% (n=54) were taking swallowed topical steroids (STS), 27% …
…ERD (62.8%), dysphagia (21.2%), and overlapping symptoms (16%). Proton pump inhibitor (PPI) use was reported in 91% of patients. Ineffective esophage…
… final follow-up. Procedural technical variables were recorded. Proton pump inhibitor (PPI) use and patient-reported satisfaction were assessed.Resul…
…opic reassessment following medical optimisation with high dose proton pump inhibitor. p53 immunohistochemistry showed limited sensitivity for predic…
…f stable therapy (food elimination diet, proton pump inhibitor, budesonide orodispersible tablets (BOTs), or combinations). All patients completed the Dysphagia …
…st recent clinic letter) were reflux (32%) and dysphagia (28%). Proton pump inhibitor (PPI) use was high (81%).Both anticentromere (n=57) and anti-Sc…
…Current guidelines do not recommend routine proton pump inhibitor (PPI) use after endoscopic variceal ligation (EVL) because of l…
…s were unaware of the high financial and environmental costs of omeprazole suspension. All participants found the draft decision aid useful and parti…
…magnesaemia is a common clinical finding and often secondary to proton pump inhibitor or excessive alcohol use. This case illustrates a rare presenta…
…s (OR 0.31, 95% CI 0.08 to 0.87), and (2) long-term exposure to proton pump inhibitor (PPI) therapy (OR 0.18, 95% CI 0.09 to 0.34). Model extension a…